VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
HAE
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HAEHaemonetics Corporation
$74.88$3.5B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksHAEQuarterly Financials

Haemonetics Corporation (HAE) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Haemonetics Corporation (HAE) quarterly income statement — complete revenue, gross profit & net income history

HAE Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ4'26Q3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22
Sales/Revenue346.35M338.97M327.31M321.39M330.6M348.54M345.51M336.17M343.29M336.25M318.18M311.33M304.42M305.3M297.49M261.46M265M259.77M239.9M228.53M
Revenue Growth %4.76%-2.75%-5.27%-4.4%-3.7%3.66%8.59%7.98%12.77%10.14%6.96%19.08%14.87%17.53%24.01%14.41%17.76%8.07%14.52%16.85%
Cost of Goods Sold148.14M147.56M143.89M129.53M148.68M148.63M154.31M156.88M154.35M151.32M147.62M143.86M140.16M146.64M139.58M119.4M110.84M121.39M117.15M118.19M
COGS % of Revenue42.77%43.53%43.96%40.3%44.97%42.64%44.66%46.67%44.96%45%46.39%46.21%46.04%48.03%46.92%45.67%41.83%46.73%48.83%51.72%
Gross Profit198.21M191.41M183.42M191.86M181.92M199.91M191.2M179.29M188.94M184.93M170.57M167.47M164.25M158.66M157.91M142.06M154.16M138.38M122.75M110.34M
Gross Margin %57.23%56.47%56.04%59.7%55.03%57.36%55.34%53.33%55.04%55%53.61%53.79%53.96%51.97%53.08%54.33%58.17%53.27%51.17%48.28%
Gross Profit Growth %8.95%-4.26%-4.07%7.01%-3.72%8.1%12.1%7.06%15.03%16.56%8.02%17.89%6.55%14.66%28.64%28.75%38.62%15.12%16.34%21.88%
Operating Expenses146.76M121.85M116.14M137.99M130.46M140.89M139.5M139.53M159M138.95M135.26M113.81M129M115.38M111.17M111.29M134.96M102.73M98.24M108.95M
OpEx % of Revenue42.37%35.95%35.48%42.93%39.46%40.42%40.38%41.51%46.32%41.32%42.51%36.56%42.37%37.79%37.37%42.57%50.93%39.55%40.95%47.67%
Selling, General & Admin121.83M107.56M101.62M0114.5M000115.12M00095.43M00096.41M000
SG&A % of Revenue35.17%31.73%31.05%-34.63%---33.54%---31.35%---36.38%---
Research & Development14.45M14.29M14.52M16.26M15.96M15.83M14.14M14.45M24.46M13.27M12.66M12.65M24.14M12.69M10.9M10.9M21.61M10.04M10.85M12.7M
R&D % of Revenue4.17%4.21%4.44%5.06%4.83%4.54%4.09%4.3%7.12%3.94%3.98%4.06%7.93%4.16%3.66%4.17%8.15%3.86%4.52%5.56%
Other Operating Expenses1000K001000K01000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K
Operating Income51.45M69.56M67.28M53.87M51.46M59.03M51.7M39.76M29.94M45.98M35.3M53.66M35.26M43.28M46.73M30.77M19.2M35.65M24.51M1.39M
Operating Margin %14.85%20.52%20.55%16.76%15.57%16.94%14.96%11.83%8.72%13.67%11.1%17.24%11.58%14.18%15.71%11.77%7.24%13.72%10.22%0.61%
Operating Income Growth %-0.03%17.84%30.14%35.51%71.87%28.39%46.44%-25.91%-15.07%6.24%-24.46%74.4%83.63%21.4%90.66%2113.45%190.67%-11.81%-58.3%-88.13%
EBITDA51.45M96.94M95.53M82.63M79.67M88.05M80.91M68.89M48.98M69.51M58.46M76.55M50.61M66.85M70.52M52.86M41.21M60.02M51.69M22.78M
EBITDA Margin %14.85%28.6%29.19%25.71%24.1%25.26%23.42%20.49%14.27%20.67%18.37%24.59%16.62%21.9%23.7%20.22%15.55%23.1%21.55%9.97%
EBITDA Growth %-35.43%10.1%18.07%19.94%62.66%26.68%38.42%-10%-3.21%3.98%-17.1%44.81%22.8%11.38%36.43%132.06%5507.07%-1.93%-37.1%-23.9%
D&A (Non-Cash Add-back)027.39M28.25M28.76M28.21M29.02M29.22M29.14M19.04M23.53M23.15M22.89M15.35M23.57M23.79M22.1M22.01M24.37M27.18M21.39M
EBIT51.45M69.56M67.28M64.94M51.46M66.11M59.76M50.98M49.4M58.99M42.62M53.65M46.26M43.32M47.09M30.72M33.77M35.57M25.2M-4.79M
Net Interest Income-5.37M-8.12M-7.21M-4.07M1.39M-9.11M-6.99M6.96M-6.53M-1.95M-2.47M-2.07M-2.63M-1.05M-5.67M-5.27M-3.87M-4.26M-4.59M-4.4M
Interest Income00001.39M006.96M000000000000
Interest Expense5.37M8.12M7.21M4.07M09.11M6.99M06.53M1.95M2.47M2.07M2.63M1.05M5.67M5.27M3.87M4.26M4.59M4.4M
Other Income/Expense-79.85M-9.59M-15.99M-8.7M19.27M-9.11M-6.99M6.96M-6.53M-1.95M-2.47M-2.07M-2.63M-1.05M-5.67M-5.27M-3.87M-4.26M-4.59M-4.4M
Pretax Income-28.4M59.98M51.28M45.17M70.74M49.92M44.7M46.71M23.41M44.03M32.83M51.59M32.63M42.22M41.06M25.49M15.33M31.39M19.92M-3.01M
Pretax Margin %-8.2%17.69%15.67%14.05%21.4%14.32%12.94%13.9%6.82%13.09%10.32%16.57%10.72%13.83%13.8%9.75%5.78%12.08%8.3%-1.32%
Income Tax-8.25M15.23M12.6M11.14M12.76M12.42M10.87M8.34M3.05M12.79M7.92M10.55M3.24M9.28M7.86M5.62M5.59M8.16M5.07M1.45M
Effective Tax Rate %29.06%25.4%24.57%24.66%18.03%24.89%24.32%17.85%13.01%29.04%24.13%20.45%9.94%21.98%19.15%22.03%36.45%25.98%25.43%-48.07%
Net Income-20.15M44.74M38.68M34.03M57.98M37.49M33.83M38.37M20.37M31.24M24.91M41.04M29.38M32.94M33.2M19.88M9.74M23.23M14.86M-4.45M
Net Margin %-5.82%13.2%11.82%10.59%17.54%10.76%9.79%11.41%5.93%9.29%7.83%13.18%9.65%10.79%11.16%7.6%3.68%8.94%6.19%-1.95%
Net Income Growth %-134.75%19.33%14.34%-11.32%184.68%20.02%35.82%-6.5%-30.68%-5.17%-24.97%106.48%201.64%41.8%123.46%546.27%188.23%-27.13%-69.12%-142.31%
Net Income (Continuing)-20.15M44.74M38.68M34.03M57.98M37.49M33.83M38.37M20.37M31.24M24.91M41.04M29.38M32.94M33.2M19.88M9.74M23.23M14.86M-4.45M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.440.950.810.701.170.740.660.740.400.610.480.800.570.640.640.380.190.450.29-0.09
EPS Growth %-137.61%28.38%22.73%-5.41%192.5%21.31%37.5%-7.5%-29.82%-4.69%-25%110.53%200%42.22%120.69%534.78%186.36%-27.42%-69.15%-141.62%
EPS (Basic)-0.440.960.810.711.170.750.660.750.400.620.490.810.580.650.650.390.190.450.29-0.09
Diluted Shares Outstanding46.22M46.99M47.66M48.35M49.48M50.64M51.24M51.56M51.41M51.45M51.4M51.34M51.22M51.22M51.56M51.68M51.35M51.34M51.46M50.94M
Basic Shares Outstanding46.22M46.79M47.59M48.11M49.19M50.29M50.9M50.94M50.79M50.77M50.73M50.54M50.45M50.51M50.95M51.22M51.12M51.09M51.04M49.49M
Dividend Payout Ratio--------------------